(Q48873124)

English

Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

0 references

Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO). (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

1 reference

based on heuristic

inferred from title

medical oncology

1 reference

based on heuristic

inferred from title

Fortunato Ciardiello

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

Paolo Giovanni Casali

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

Alexander Eggermont

6

object named as

A Eggermont

0 references

object named as

D Arnold

2

0 references

author name string

A Cervantes

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

J-Y Douillard

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

A Eggermont

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

A Eniu

7

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

K McGregor

8

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

S Peters

9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

M Piccart

10

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

R Popescu

11

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

E Van Cutsem

12

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

C Zielinski

13

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

R Stahel

14

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

publication date

20 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

25

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

1673-1678

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

International network of cancer genome projects

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Lessons from the cancer genome

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Journeys into the genome of cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Cancer pharmacogenomics: early promise, but concerted effort needed

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Clinical whole-exome sequencing for the diagnosis of mendelian disorders

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

The causes and consequences of genetic heterogeneity in cancer evolution

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

The evolution of the unstable cancer genome

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Genomic medicine frontier in human solid tumors: prospects and challenges

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Cancer evolution: the final frontier of precision medicine?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Existing and emerging technologies for tumor genomic profiling

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

European consensus conference for external quality assessment in molecular pathology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Preparing for Responsible Sharing of Clinical Trial Data

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Knowledge engineering for health: a new discipline required to bridge the "ICT gap" between research and healthcare

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Reflections on market access for personalized medicine: recommendations for Europe

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Genomics-driven oncology: framework for an emerging paradigm

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Personalised cancer management: closer, but not here yet.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU217

21 January 2018

Identifiers

10.1093/ANNONC/MDU217

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

release_jpps7fh45rfwnb2xscsewaqja4

1 reference

https://api.fatcat.wiki/v0/release/jpps7fh45rfwnb2xscsewaqja4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24950979

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48873124&oldid=1835800743"